Global Automated Breast Ultrasound System (ABUS) Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

The global automated breast ultrasound system (ABUS) market is segmented has been segmented by Product, End User, and Geograph by product into standalone systems, workstation-based systems, and handheld systems. Standalone systems hold the largest share due to their high efficiency and integration of advanced imaging technologies for early and accurate breast cancer detection, particularly in women with dense breast tissue. Workstation-based systems are gaining traction in diagnostic centers and hospitals, offering streamlined workflows and enhanced image analysis capabilities. Handheld systems, although smaller in market share, are growing due to their portability and affordability, making them accessible for smaller clinics and emerging markets.

By end user, the market is categorized into hospitals, diagnostic imaging centers, and ambulatory surgical centers (ASCs). Hospitals dominate the segment owing to their comprehensive diagnostic facilities and increasing adoption of ABUS for routine screening and cancer detection. Diagnostic imaging centers are witnessing growth driven by their specialized services and focus on non-invasive diagnostic tools. ASCs are emerging as a key segment due to their cost-effectiveness and shorter patient turnaround times, aligning with the increasing emphasis on outpatient care in healthcare systems globally.

Geographically, the ABUS market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America leads the market due to a high prevalence of breast cancer, established healthcare infrastructure, and widespread adoption of advanced diagnostic technologies. Europe follows, supported by growing awareness and government initiatives for early breast cancer detection. The Asia-Pacific region is expected to experience rapid growth due to increasing healthcare expenditure, rising breast cancer incidence, and expanding access to advanced imaging systems. Latin America and the Middle East & Africa are gradually evolving markets, with improving healthcare systems and growing awareness driving adoption in these regions.

Global Automated Breast Ultrasound System (ABUS) Segment Analysis

In this report, the Global Automated Breast Ultrasound System (ABUS) Market has been segmented by Product, End User, and Geography.

Global Automated Breast Ultrasound System (ABUS) Market, Segmentation by Product

The Global Automated Breast Ultrasound System (ABUS) Market has been segmented by Product into Automated Breast Ultrasound System (ABUS), Automated Breast Volume Scanners (ABVS), and Others.

ABUS systems automate the ultrasound imaging process, offering consistent and reproducible results while reducing operator variability. These systems are designed to improve the detection of breast abnormalities, particularly in women with dense breast tissue, where mammography may be less effective. ABUS systems typically feature advanced imaging algorithms and ergonomic designs to enhance diagnostic accuracy and patient comfort during breast examinations.

Another notable product segment within the Global Automated Breast Ultrasound System (ABUS) Market is Automated Breast Volume Scanners (ABVS). ABVS systems utilize advanced technology to acquire three-dimensional volumetric images of the breast, providing comprehensive coverage and detailed visualization of breast tissue. These systems offer enhanced diagnostic capabilities and improved workflow efficiency compared to traditional two-dimensional ultrasound imaging. ABVS systems are widely used in breast cancer screening and diagnosis, offering valuable insights into breast anatomy and pathology.

In addition to ABUS and ABVS systems, the Global Automated Breast Ultrasound System (ABUS) Market encompasses other product categories catering to specific clinical needs and preferences. These may include specialized ultrasound probes, accessories, and software solutions designed to enhance the functionality and performance of ABUS systems. Other innovative technologies such as handheld ultrasound devices and automated breast biopsy systems may also complement ABUS imaging in certain clinical scenarios, providing comprehensive breast care solutions for healthcare providers and patients alike.

Global Automated Breast Ultrasound System (ABUS) Market, Segmentation by End User

The Global Automated Breast Ultrasound System (ABUS) Market has been segmented by End User into Hospitals and Diagnostic Imaging Centers.

Hospitals represent the largest segment in the global automated breast ultrasound system (ABUS) market by end user. The comprehensive diagnostic capabilities of hospitals make them a preferred choice for patients undergoing breast cancer screening and diagnosis. With increasing integration of advanced imaging technologies like ABUS, hospitals are enhancing their ability to detect breast cancer early, especially in women with dense breast tissue. The availability of skilled radiologists, robust infrastructure, and ongoing investments in upgrading diagnostic equipment further bolster the dominance of this segment.

Diagnostic imaging centers are gaining significant traction in the ABUS market as specialized facilities dedicated to non-invasive diagnostic procedures. These centers cater to a growing population seeking efficient and focused diagnostic services outside traditional hospital settings. ABUS systems are particularly popular in these centers due to their ability to provide accurate and comprehensive imaging results with shorter patient turnaround times. Additionally, the rising emphasis on outpatient care and cost-effective diagnostics has fueled the demand for ABUS in standalone imaging centers.

Both hospitals and diagnostic imaging centers are integral to the ABUS market’s growth, driven by the increasing prevalence of breast cancer and rising awareness about early detection. While hospitals benefit from comprehensive patient care capabilities, diagnostic imaging centers capitalize on convenience, affordability, and specialization. The demand for ABUS in these segments is further supported by technological advancements, including AI-driven imaging solutions, which enhance diagnostic accuracy and operational efficiency. The complementary roles of these end users ensure widespread adoption of ABUS systems across diverse healthcare settings.

Global Automated Breast Ultrasound System (ABUS) Market, Segmentation by Geography

In this report, the Global Automated Breast Ultrasound System (ABUS) Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Automated Breast Ultrasound System (ABUS) Market Share (%), by Geographical Region, 2024

North America holds a significant share of the ABUS market, driven by advanced healthcare infrastructure, robust research and development activities, and high awareness levels regarding breast cancer screening. The region benefits from early adoption of innovative medical technologies and favorable reimbursement policies, fostering the widespread adoption of ABUS systems across hospitals, diagnostic imaging centers, and breast care facilities.

Europe is another prominent market for ABUS systems, characterized by a strong emphasis on preventive healthcare and cancer screening programs. The region boasts sophisticated healthcare systems, extensive regulatory frameworks, and collaborative efforts between public and private sectors to improve breast cancer detection and treatment. ABUS adoption is growing steadily across European countries, supported by government initiatives, technological advancements, and increasing patient awareness.

The Asia Pacific region presents significant growth opportunities for the ABUS market, fueled by rising healthcare investments, expanding access to healthcare services, and growing breast cancer awareness campaigns. Countries such as China, India, Japan, and South Korea are witnessing increasing adoption of ABUS systems, driven by a growing burden of breast cancer and efforts to enhance early detection and diagnosis capabilities.

In the Middle East and Africa (MEA) region, the ABUS market is evolving, supported by improving healthcare infrastructure, rising healthcare expenditures, and initiatives to address breast cancer disparities. While challenges such as limited access to advanced healthcare facilities and socioeconomic factors may impede market growth, efforts to strengthen healthcare systems and expand screening programs are driving demand for ABUS technology.

Latin America represents another emerging market for ABUS systems, characterized by a growing burden of breast cancer and increasing healthcare investments. Countries in the region are investing in breast cancer awareness campaigns, screening initiatives, and healthcare infrastructure development, creating opportunities for ABUS manufacturers to expand their presence and address unmet needs in breast imaging services.

This report provides an in depth analysis of various factors that impact the dynamics of Global Automated Breast Ultrasound System (ABUS) Market. These factors include; Market Drivers, Restraints, and Opportunities.

Drivers, Restraints and Opportunity Analysis

Drivers

• Increasing breast cancer prevalence
• Growing adoption of screening programs
• Rising awareness of early detection
• Favorable reimbursement policies

• Aging population driving demand - The aging population is a significant driver in the global healthcare landscape, particularly in the context of breast imaging technologies such as Automated Breast Ultrasound Systems (ABUS). As populations age, the incidence of breast cancer and other age-related health conditions tends to increase. Breast cancer, in particular, is more common among older individuals, with the risk rising significantly after the age of 50. There is a growing demand for advanced screening and diagnostic tools capable of detecting breast abnormalities in this demographic.

  The aging population drives demand for ABUS systems as it necessitates more comprehensive and effective breast cancer screening strategies. Mammography, the primary screening modality for breast cancer, may be less sensitive in older women due to factors such as increased breast density and age-related changes in breast tissue. ABUS systems offer an adjunct or alternative screening option, particularly for women with dense breast tissue or those who may have difficulty undergoing mammography due to physical limitations or discomfort.

  As life expectancy continues to rise globally, there is a greater emphasis on preventive healthcare and early disease detection among older adults. ABUS systems play a crucial role in this regard by providing healthcare providers with additional imaging modalities to aid in the early detection and diagnosis of breast cancer in aging populations. By offering more sensitive and accurate screening options, ABUS systems contribute to improved clinical outcomes, earlier intervention, and reduced mortality rates among older individuals at risk of breast cancer.

Restraints

• Skilled professional scarcity
• False positives concerns
• Regulatory approval challenges
• Patient discomfort during procedures

• Limited ABUS awareness - Limited awareness about Automated Breast Ultrasound Systems (ABUS) represents a notable restraint in the adoption and utilization of this technology in breast imaging. Despite its potential benefits in enhancing breast cancer detection, many healthcare providers and patients may have limited knowledge or understanding of ABUS systems and their role in breast cancer screening and diagnosis.

  This lack of awareness can hinder the widespread adoption of ABUS technology, as healthcare providers may be less inclined to incorporate it into their breast imaging protocols, and patients may not actively seek out ABUS examinations as part of their routine healthcare. Additionally, misconceptions or misunderstandings about ABUS systems, such as concerns about efficacy, safety, or radiation exposure, may further contribute to hesitancy among both providers and patients.

  Limited ABUS awareness may result in inadequate training and education among healthcare professionals, leading to suboptimal utilization of ABUS systems and potential missed opportunities for early breast cancer detection. Without sufficient awareness and understanding of ABUS technology, healthcare providers may be less likely to recommend it as a screening option, particularly in populations where mammography is considered the standard of care.

Opportunities

• Enhanced ABUS technology
• AI integration in imaging
• Screening program expansion
• Portable, cost-effective systems

• Novel application research - Novel application research presents a compelling opportunity in the realm of Automated Breast Ultrasound Systems (ABUS), offering the potential to expand the utility and effectiveness of this technology in breast imaging. By exploring innovative applications and emerging technologies, researchers can unlock new capabilities and functionalities that enhance the diagnostic accuracy, efficiency, and clinical utility of ABUS systems.

  One key opportunity lies in the development of advanced imaging algorithms and artificial intelligence (AI) technologies tailored specifically for ABUS. By leveraging machine learning and deep learning algorithms, researchers can improve the interpretation of ABUS images, automate lesion detection and characterization, and enhance workflow efficiency. These AI-driven tools have the potential to assist radiologists in identifying subtle abnormalities, reducing interpretation time, and improving diagnostic accuracy.

  Another promising avenue for novel application research is the integration of ABUS with other imaging modalities, such as mammography, magnetic resonance imaging (MRI), and positron emission tomography (PET). By combining complementary imaging techniques, researchers can create multimodal imaging approaches that provide comprehensive assessment of breast tissue morphology, function, and molecular characteristics. This integrated approach may offer synergistic benefits in terms of early detection, characterization, and treatment planning for breast cancer and other breast conditions.

Key players in Global Automated Breast Ultrasound System (ABUS) Market include,

• GE Healthcare
• Siemens Healthineers
• Hitachi Healthcare
• SonoCine Inc
• QT Ultrasound
• Koninklijke Philips NV
• Delphinus Medical Technologies Inc
• Hologic Inc
• Fujifilm Holdings Corporation
• Siemens AG
• SuperSonic Imagine
• Canon Medical Systems Corporation
• SonoSim Inc
• Esaote SpA
• Samsung Medison Co Ltd

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis